Mucinex and Humibid will soon be the only long-acting guaifenesin products left standing

Mucinex and Humibid will soon be the only long-acting guaifenesin products left standing.

The FDA already ordered all other SINGLE-ingredient long-acting guaifenesin products off the market in 2003 when Mucinex came out.

Now they are also targeting unapproved COMBO products that contain long-acting guaifenesin (Guaifenex, Crantex, etc).

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote